⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Terephthalic Acid SCHEMBL27982891 | 0.78 | TDP1 (0.52) | — | |
| SCHEMBL3800523 | 0.77 | — | — | |
| SCHEMBL6671112 | 0.75 | — | — | |
| Water SCHEMBL11436356 | 0.75 | ALDH1A1 (0.38) | — | |
| SCHEMBL6671110 | 0.75 | — | — | |
| SCHEMBL28959540 | 0.73 | — | — | |
| SCHEMBL11501687 | 0.73 | — | — | |
| SCHEMBL10823914 | 0.73 | — | — | |
| SCHEMBL11413190 | 0.73 | — | — | |
| SCHEMBL5378294 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114956918-A | Non-explosive emulsion explosive smell simulation agent and preparation technology | 管晓渝 | 2022-08-30 | — | — | CN | claimed |
| US-12012375-B2 | Prostaglandin F2 alpha derivatives for decreasing intraocular pressure | GURUS BIOPHARM LIMITED LIABILITY COMPANY (RU) | 2024-06-18 | — | — | US | disclosed |
| CN-112154139-B | Prostaglandin F2 alpha derivatives for ocular hypotension | 古鲁生物制药有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-114956918-A | Non-explosive emulsion explosive smell simulation agent and preparation technology | 管晓渝 | 2022-08-30 | — | — | CN | disclosed |
| CN-109014242-B | Preparation method of high-length-diameter ratio nano silver wire | 昆明理工大学 | 2021-08-20 | — | — | CN | disclosed |
| US-20210230111-A1 | PROSTAGLANDIN F2 ALPHA DERIVATIVES FOR DECREASING INTRAOCULAR PRESSURE | KOFF INVESTMENTS LLP (GB) | 2021-07-29 | — | — | US | disclosed |
| CN-111170933-B | Preparation method of 2-chloro-5-nitropyridine | 新发药业有限公司 | 2021-07-20 | — | — | CN | disclosed |
| CN-109374566-B | Method and system for measuring content of mixed alcohol | 湖北航天化学技术研究所 | 2021-06-11 | — | — | CN | disclosed |
| EP-3795562-A1 | PROSTAGLANDIN F2 ALPHA DERIVATIVES FOR DECREASING INTRAOCULAR PRESSURE | Gurus Biopharm Limited Liability Company (RU) | 2021-03-24 | — | — | EP | disclosed |
| CN-112154139-A | Prostaglandin F2 alpha derivatives for lowering intraocular pressure | 古鲁生物制药有限公司 | 2020-12-29 | — | — | CN | disclosed |
| CN-106572957-B | Skin color improving agent and composition for improving skin color | 昭和电工株式会社 | 2020-03-27 | — | — | CN | disclosed |
| WO-2019176079-A1 | BIODEGRADABLE COMPOUND, LIPID PARTICLE, LIPID PARTICLE-CONTAINING COMPOSITION, AND KIT | 株式会社 東芝 | 2019-09-19 | — | — | WO | disclosed |
| US-9125856-B1 | Method of stabilizing human eye tissue | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2015-09-08 | — | — | US | disclosed |
| CN-102203055-A | Nitric oxide releasing amino acid ester compound, composition and method of use | NITROGENIX INC | 2011-09-28 | — | — | CN | disclosed |
| US-7868035-B2 | Therapeutic esters | ALLERGAN, INC. (US) | 2011-01-11 | — | — | US | disclosed |
| US-7691785-B2 | Pyridine-3-ketone compound; plant growth controllers | SYNGENTA CROP PROTECTION, INC. (US) | 2010-04-06 | — | — | US | disclosed |
| US-20090012145-A1 | THERAPEUTIC ESTERS | WOODWARD DAVID F | 2009-01-08 | — | — | US | disclosed |
| US-20080274891-A1 | SUBSTITUTED PYRIDINE HERBICIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2008-11-06 | — | — | US | disclosed |
| US-7378375-B1 | Substituted pyridine herbicides | SYNGENTA CROP PROTECTION, INC. (US) | 2008-05-27 | — | — | US | disclosed |
| WO-2006083841-A2 | THERAPEUTIC ESTERS | ALLERGAN, INC. (US) | 2006-08-10 | — | — | WO | disclosed |